This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jatin P. Shah, MD; Dennis H. Kraus, MD; Mark H. Bilsky, MD; Philip H. Gutin, MD; Louis H. Harrison, MD; Elliot W. Strong, MD

Arch Otolaryngol Head Neck Surg. 1997;123(12):1312-1317.

Abstract
Objectives
To review our experience with craniofacial resection for malignant neoplasms of the anterior skull base and report long-term results, and to analyze survival in terms of the overall experience, tumor histological diagnoses, and tumor extent. Also, to report complications of this surgical procedure.

Design
Retrospective review.

Setting
Tertiary cancer facility.

Patients
We evaluated 115 consecutive patients undergoing craniofacial resection for malignant neoplasms involving the anterior skull base. Forty-five (39%) presented with recurrent or persistent disease after prior therapy.

Main Outcome Measures
Survival was evaluated with the Kaplan-Meier product limit method and comparisons between individual subgroups were performed using the log-rank test.

Results
The operative mortality rate was 3.5%. Major complications occurred in 40 patients (35%). For the entire group, disease-specific survival rates were 58% and 48% at 5 and 10 years, respectively. The highest survival rate was observed in patients with esthesioneuroblastoma and lowest in those with mucosal melanoma. Survival was significantly better for those whose tumors could be excised with a limited resection in comparison with those requiring an extended procedure (P=.009).

Conclusions
A 23-year experience with craniofacial resection performed for malignant tumors involving the anterior skull base confirms the durable results obtained with this intervention. The diversity of histological diagnoses, site of origin, extent of tumor invasion, and impact of prior therapy hampers any attempt at reporting meaningful survival statistics for comparison with other series or other means of treatment.

Arch Otolaryngol Head Neck Surg. 1997;123:1312-1317

Author Affiliations
From the Head and Neck Service (Drs Shah, Kraus, and Strong), and Neurosurgery Service (Drs Bilsky and Gutin), Department of Surgery, and the Department of Radiation Oncology (Dr Harrison), Memorial Sloan-Kettering Cancer Center, New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Sensitivity and Specificity of High-Resolution Imaging in Evaluating Perineural Spread of Adenoid Cystic Carcinoma to the Skull Base
Hanna et al.
Arch Otolaryngol Head Neck Surg 2007;133:541-545.
ABSTRACT | FULL TEXT  

Craniofacial Resection for Malignant Melanoma of the Skull Base: Report of an International Collaborative Study
Ganly et al.
Arch Otolaryngol Head Neck Surg 2006;132:73-78.
ABSTRACT | FULL TEXT  

The Transglabellar/Subcranial Approach to the Anterior Skull Base: A Review of 72 Cases
Kellman and Marentette
Arch Otolaryngol Head Neck Surg 2001;127:687-690.
ABSTRACT | FULL TEXT  

Adenocarcinoma of the Ethmoidal Sinus Complex: Surgical Debulking and Topical Fluorouracil May Be the Optimal Treatment
Knegt et al.
Arch Otolaryngol Head Neck Surg 2001;127:141-146.
ABSTRACT | FULL TEXT  

A New Classification for Malignant Tumors Involving the Anterior Skull Base
Cantu et al.
Arch Otolaryngol Head Neck Surg 1999;125:1252-1257.
ABSTRACT | FULL TEXT